Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
 
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research
 

Science Writers Media Briefing

Date: September 13, 2004
Time: 11:00 AM–12:30 PM
Place: Natcher Conference Center, NIH Bethesda

Program Agenda

Welcome by Moderator

  • Anna Barker, Ph.D., Deputy Director for Advanced Technologies and Strategic Partnerships, National Cancer Institute

Overview: Going Small for Big Advances:
The impact of nanotechnology on cancer research

  • Andrew von Eschenbach, M.D., Director, National Cancer Institute

Briefing Presentation #1:
Nanotechnology: what is it, how does it work, what's the promise?

  • Richard Smalley, Ph.D., Professor of Chemistry, Physics, Astronomy, and Nanotechnology, Rice University
  • Reporter Q&As

Briefing Presentation #2:
The Intersection of Nanotechnology and Cancer Research

  • Today and tomorrow
    • Mauro Ferrari, Ph.D., Special Expert to the NCI on Nanotechnology and Professor of Biomedical Engineering, Ohio State University
  • The clinical perspective
    • Samuel Wickline, M.D., Professor of Medicine, Physics and Biomedical Engineering, Washington University
  • Reporter Q&As

Briefing Presentation # 3:
Moving nanotechnology forward: the safety and ethical considerations

  • Janet Woodcock, M.D., Acting Director Commissioner for Operations, U.S. Food and Drug Administration
  • Vicki Colvin, Ph.D., Director of the Center for Biological and Environmental Nanotechnology and Associate Professor of Chemistry, Rice University
  • Reporter Q&As

Briefing Presentation #4: The nation's commitment to nanotechnology

  • The Honorable Phillip J. Bond, Under Secretary of Commerce for Technology
  • Reporter Q&As

Conclusion/Thank you

  • Anna Barker, Ph.D., Deputy Director for Advanced Technologies and Strategic Partnerships, National Cancer Institute